BioNess announced today that it won CE Mark approval for its StimRouter neuromodulation system indicated for the treatment of fecal incontinence. The StimRouter system previously won approval for treating chronic pain and overactive bladder. The small implantable system targets the tibial nerve near the ankle. Patients undergoing the StimRouter implant procedure receive one incision as […]
Bioness
Bioness launches peripheral nerve stim registry
Bioness today launched a patient registry for people using its StimRouter neuromodulation system for peripheral nerve stimulation. Starting in the first quarter of 2019, patients will be able to opt into the StimRouter Registry, according to the Valencia, Calif.-based company. Bioness’ StimRouter was launched in 2016 and the company touts it as the first neuromodulation […]
Bioness launches StimRouter neuromod system in Canada
Rehabilitation device maker Bioness today touted the launch of its StimRouter neuromodulation system in Canada, and said that the system had been implanted in its first procedures in the region. The first implantations of the device were performed at Toronto’s Women’s College Hospital, the Valencia, Calif.-based company said. “Significant advances in the miniaturization and durability of […]
7 medtech stories we missed: Feb. 10, 2017
From Glytec partnering to beat diabetes to Biolase, Gramercy Extremity Orthopedics and more getting FDA clearances, here are 7 recent medtech stories we missed this week, but were still worth mentioning. 1. BioTime proposes public offering of common stock Clinical-stage biotechnology company BioTech is intending to offer common stock shares in an underwritten public offering. […]